scholarly article | Q13442814 |
P356 | DOI | 10.1176/APPI.AJP.161.11.2108 |
P8608 | Fatcat ID | release_pgjaa74fw5hhjls7spffa4wiwe |
P698 | PubMed publication ID | 15514413 |
P50 | author | Mary C. Zanarini | Q60616491 |
Frances Rachel Frankenburg | Q60646412 | ||
D Bradford Reich | Q107533282 | ||
P2093 | author name string | John Hennen | |
Kenneth R Silk | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
borderline personality disorder | Q208166 | ||
comorbidity | Q1414874 | ||
P304 | page(s) | 2108-2114 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | American Journal of Psychiatry | Q1935368 |
P1476 | title | Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission | |
P478 | volume | 161 |
Q34554331 | A Focused Systematic Review of Pharmacological Treatment for Borderline Personality Disorder |
Q64993200 | A Life Span Perspective on Borderline Personality Disorder. |
Q36135336 | A Systematic Review of Personality Disorders and Health Outcomes |
Q37416027 | A comparison of borderline personality disorder with and without eating disorders |
Q30428539 | A developmental neuroscience of borderline pathology: emotion dysregulation and social baseline theory |
Q22241549 | A feasibility study of mindfulness-based cognitive therapy for individuals with borderline personality disorder |
Q50880331 | A momentary assessment study of the reputed emotional phenotype associated with borderline personality disorder. |
Q37704891 | A pilot randomized controlled trial of Dialectical Behavior Therapy with and without the Dialectical Behavior Therapy Prolonged Exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. |
Q40493860 | A psychometric investigation of gender differences and common processes across borderline and antisocial personality disorders. |
Q38004087 | A systematic review of dialectical behavior therapy for the treatment of eating disorders |
Q51749419 | Abnormalities in gray matter volume in patients with borderline personality disorder and their relation to lifetime depression: A VBM study. |
Q34510610 | Affective disorders among patients with borderline personality disorder |
Q30842229 | Anger and aggression in borderline personality disorder and attention deficit hyperactivity disorder - does stress matter? |
Q34623377 | Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? |
Q48797436 | Associations between identity diffusion, Axis II disorder, and psychopathology in inpatients with borderline personality disorder |
Q92557336 | Autism and psychosis as diametrical disorders of embodiment |
Q43503779 | Axis I and II comorbidity and psychosocial functioning in female adolescents with borderline personality disorder |
Q57820405 | Body dysmorphic disorder in patients with borderline personality disorder: prevalence, clinical characteristics, and role of childhood trauma |
Q33569687 | Borderline personality disorder and comorbid addiction: epidemiology and treatment |
Q92556025 | Borderline personality disorder and emotion dysregulation |
Q36254513 | Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment |
Q35951671 | Borderline personality symptoms in short-term and long-term abstinent alcohol dependence |
Q39000906 | Bullying involvement in relation to personality disorders: a prospective follow-up of 508 inpatient adolescents |
Q34274132 | Characterizing eating disorders in a personality disorders sample |
Q36033769 | Characterizing emotional dysfunction in borderline personality, major depression, and their co-occurrence |
Q43659226 | Childhood maltreatment in patients with somatization disorder |
Q36915195 | Childhood trauma, borderline personality, and eating disorders: a developmental cascade |
Q46655728 | Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy |
Q53423501 | Comorbid Diagnosis of Psychotic Disorders in Borderline Personality Disorder: Prevalence and Influence on Outcome. |
Q38140705 | Comorbid personality disorders and violent behavior in psychotic patients |
Q34406137 | Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population |
Q36246780 | Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database |
Q41137973 | Comparing Effectiveness of Treatments for Borderline Personality Disorder in Communal Mental Health Care: The Oulu BPD Study |
Q50582894 | Construct Validity of the DSM-5 Section III Personality Trait Profile for Borderline Personality Disorder. |
Q35217429 | Correlates, stability and predictors of borderline personality disorder among previously suicidal youth |
Q36510893 | Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery |
Q51858385 | Depressive comorbidity in personality disorders. |
Q50059215 | Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years |
Q37051670 | Developmental differences in diffusion tensor imaging parameters in borderline personality disorder. |
Q33553137 | Dialectical behavior therapy for substance abusers |
Q36088760 | Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls |
Q34559452 | Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity |
Q34352918 | Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence |
Q43075511 | Dysregulation of regional endogenous opioid function in borderline personality disorder. |
Q36359767 | EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER |
Q85075488 | Eating disorder symptoms and borderline personality symptomatology |
Q36083269 | Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder - a pilot study |
Q48051504 | Evaluation of changes in prescription medication use after a residential treatment programme for borderline personality disorder. |
Q37841775 | Evidence-based pharmacotherapy for personality disorders |
Q36403227 | Examining challenging behaviors of clients with borderline personality disorder |
Q45247344 | Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder |
Q60640286 | Exploring General Practitioners’ Views and Experiences of Providing Care to People with Borderline Personality Disorder in Primary Care: A Qualitative Study in Australia |
Q37059238 | Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up |
Q86877345 | Focused vs. Broad enhanced cognitive behavioral therapy for bulimia nervosa with comorbid borderline personality: A randomized controlled trial |
Q38831637 | Genetic and environmental influences on the codevelopment among borderline personality disorder traits, major depression symptoms, and substance use disorder symptoms from adolescence to young adulthood |
Q33626096 | Hypothalamic pituitary thyroid axis and exposure to interpersonal violence in childhood among women with borderline personality disorder |
Q36605170 | Identifying latent trajectories of personality disorder symptom change: growth mixture modeling in the longitudinal study of personality disorders |
Q33824370 | Impact of therapist change after initial contact and traumatic burden on dropout in a naturalistic sample of inpatients with borderline pathology receiving dialectical behavior therapy |
Q52898956 | Impaired decision making and feedback evaluation in borderline personality disorder. |
Q34459466 | In-depth study of personality disorders in first-admission patients with substance use disorders |
Q37964559 | Long-term outcomes in borderline psychopathology: old assumptions, current findings, and new directions |
Q36416810 | Management of borderline personality disorder |
Q64938243 | Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder - the impact of clinical severity. |
Q92649835 | Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial |
Q36719875 | New frontiers in the role of hospitalization for patients with personality disorders |
Q37345068 | New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the Collaborative Longitudinal Personality Disorders Study |
Q37935806 | Off-label use of atypical antipsychotics in personality disorders. |
Q36142670 | Pathological personality traits among patients with absent, current, and remitted substance use disorders |
Q35016163 | Personality and psychopathology: the dangers of premature closure |
Q37703213 | Personality disorders and mood disorders: perspectives on diagnosis and classification from studies of longitudinal course and familial associations |
Q34498313 | Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings |
Q36072750 | Personality disorders associated with full and partial posttraumatic stress disorder in the U.S. population: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions |
Q50611471 | Personality disorders in the workplace. |
Q24234749 | Pharmacological interventions for borderline personality disorder |
Q94348315 | Pharmacological interventions for people with borderline personality disorder |
Q37589844 | Prevalence and risk factors for irritable bowel syndrome in recovered and non-recovered borderline patients over 10 years of prospective follow-up |
Q37252602 | Psychiatric Comorbidity in Alcohol Dependence |
Q37055695 | Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients |
Q91477754 | Psychometric properties of the Spanish version of the involvement evaluation questionnaire in caregivers of patients with borderline personality disorders |
Q42163532 | Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics |
Q34771403 | Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up |
Q36084686 | Rejection sensitivity and symptom severity in patients with borderline personality disorder: effects of childhood maltreatment and self-esteem |
Q39429897 | Risk stratification for the early diagnosis of borderline personality disorder using psychiatric co-morbidities |
Q34603448 | Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up |
Q48122288 | Structural alterations in white-matter tracts connecting (para-)limbic and prefrontal brain regions in borderline personality disorder |
Q51660649 | Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments. |
Q44016774 | Suicide attempts in major depressed patients with personality disorder |
Q35469922 | The 10-year course of PTSD in borderline patients and axis II comparison subjects |
Q26801767 | The Lifetime Course of Borderline Personality Disorder |
Q55262466 | The Risk Factors of the Alcohol Use Disorders-Through Review of Its Comorbidities. |
Q39812349 | The clinical trajectory of patients with borderline personality disorder |
Q33875755 | The contribution of familial internalizing and externalizing liability factors to borderline personality disorder |
Q96135685 | The course of (comorbid) trauma-related, dissociative and personality disorders: two year follow up of the Friesland study cohort |
Q36552125 | The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study |
Q33729569 | The course of eating disorders in patients with borderline personality disorder: a 10-year follow-up study |
Q35569762 | The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10‐year follow‐up study |
Q47870860 | The impact of childhood traumas, depressive and anxiety symptoms on the relationship between borderline personality features and symptoms of adult attention deficit hyperactivity disorder in Turkish university students |
Q37141463 | The impact of posttraumatic stress disorder on the symptomatology of borderline personality disorder |
Q36084677 | The relationship between borderline symptoms and vantage perspective during autobiographical memory retrieval in a community sample |
Q37449605 | The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up |
Q46807192 | Three-week inpatient Cognitive Evolutionary Therapy (CET) for patients with personality disorders: evidence of effectiveness in symptoms reduction and improved treatment adherence |
Q36395463 | Time course of facial emotion processing in women with borderline personality disorder: an ERP study |
Q34068038 | Trauma-related altered states of consciousness in women with BPD with or without co-occurring PTSD. |
Q47366572 | Trauma-related dissociation: Psychological features and psychophysiological responses to script-driven imagery in borderline personality disorder |
Q36813316 | Treatment of borderline personality disorder and co-occurring anxiety disorders |
Q50596337 | Treatment of personality disorder |
Q33823729 | Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD. |
Q48286636 | Treatment progress in medium security hospital settings for women: changes in symptoms, personality and service need from admission to discharge |
Q34817261 | Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study |
Q37685521 | What Works in the Treatment of Borderline Personality Disorder |
Q39221611 | What changes when? The course of improvement during a stage-based treatment for suicidal and self-injuring women with borderline personality disorder and PTSD. |
Q36192004 | What is the impact of child abuse on gray matter abnormalities in individuals with major depressive disorder: a case control study |
Q90590661 | What we do, do not, and need to know about comorbid depression and personality disorders |
Q34584223 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders |
Q82387728 | [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment] |
Search more.